37 related articles for article (PubMed ID: 33831675)
1. Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma.
Yan JX; Li QH; Li TZ; Huang ZY; Ma YB; Chen JJ
Drug Dev Res; 2023 Sep; 84(6):1285-1298. PubMed ID: 37345274
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Antitumor Activity of 1-Substituted 1,2,3-Triazole-Mollugin Derivatives.
Luo H; Lv YF; Zhang H; Hu JM; Li HM; Liu SJ
Molecules; 2021 May; 26(11):. PubMed ID: 34071319
[TBL] [Abstract][Full Text] [Related]
3. 1,2,3-Triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitors.
Haidar S; Amesty Á; Oramas-Royo S; Götz C; El-Awaad E; Kaiser J; Bödecker S; Arnold A; Aichele D; Amaro-Luis JM; Estévez-Braun A; Jose J
Bioorg Med Chem; 2024 May; 105():117727. PubMed ID: 38669736
[TBL] [Abstract][Full Text] [Related]
4. Discovery of A Novel Series of Quinazoline-Thiazole Hybrids as Potential Antiproliferative and Anti-Angiogenic Agents.
Șandor A; Fizeșan I; Ionuț I; Marc G; Moldovan C; Oniga I; Pîrnău A; Vlase L; Petru AE; Macasoi I; Oniga O
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397456
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antihepatoma activity of guaianolide dimers derived from lavandiolide I.
Wang X; Li TZ; Ma YB; Ma WJ; Xue D; Chen JJ
Bioorg Med Chem Lett; 2024 May; 104():129708. PubMed ID: 38521176
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and antiproliferative evaluation of novel sorafenib analogs for the treatment of hepatocellular carcinoma.
Jihad MI; Mahdi MF
J Adv Pharm Technol Res; 2023; 14(3):274-279. PubMed ID: 37692003
[TBL] [Abstract][Full Text] [Related]
7. Substitution of a triazole for the central olefin in biologically active stilbenes.
Stockdale DP; Beutler JA; Wiemer DF
Bioorg Med Chem Lett; 2022 Nov; 75():128980. PubMed ID: 36096344
[TBL] [Abstract][Full Text] [Related]
8. Hypocretenolides: collective total syntheses and activities toward metastatic colon cancer.
Chen B; Zhang X; Yang Y; Xu D; Wu Q; Wang S; Bao S; Zhang X; Ding Y; Wang L; Chen Y
Chem Sci; 2024 May; 15(17):6397-6401. PubMed ID: 38699277
[TBL] [Abstract][Full Text] [Related]
9.
Sayed MM; Nabil ZI; El-Shenawy NS; Al-Eisa RA; Nafie MS
Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004390
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Characterization, Cytotoxicity Analysis and Evaluation of Novel Heterocyclic Derivatives of Benzamidine against Periodontal Disease Triggering Bacteria.
Kavitha R; Sa'ad MA; Fuloria S; Fuloria NK; Ravichandran M; Lalitha P
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830219
[TBL] [Abstract][Full Text] [Related]
11. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN.
Bhattacharya S; Sharma S; Prajapati BG
Front Oncol; 2022; 12():990841. PubMed ID: 36387097
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines.
Yang YT; Yuzbasiyan-Gurkan V
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012610
[TBL] [Abstract][Full Text] [Related]
13. Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.
Kozyra P; Pitucha M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012142
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines.
Palakhachane S; Ketkaew Y; Chuaypen N; Sirirak J; Boonsombat J; Ruchirawat S; Tangkijvanich P; Suksamrarn A; Limpachayaporn P
Bioorg Chem; 2021 Jul; 112():104831. PubMed ID: 33831675
[TBL] [Abstract][Full Text] [Related]
15. meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
Limpachayaporn P; Nuchpun S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Tangkijvanich P; Suksamrarn A
Bioorg Med Chem; 2022 Nov; 74():117048. PubMed ID: 36270111
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
[TBL] [Abstract][Full Text] [Related]
17. The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.
Oekchuae S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Boonsombat J; Ruchirawat S; Tangkijvanich P; Suksamrarn A; Limpachayaporn P
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631331
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
